Concepedia

Author

Margaret Johnson

Duke Medical CenterORCID

Also Known As

Johnson, Margaret A., Johnson, Margaret O, M Johnson, M. Johnson, M.O. Johnson, Margaret Johnson, Margaret Johnson MCHS, SRCh, DipFE, PhD, Margaret O Johnson, Margaret O. Johnson

145

Publications

746

Citations

15

H-Index

42

Concepts

All Affiliations

Duke Medical CenterUniversity of CambridgeDuke University HospitalAddenbrooke's HospitalUniversity College London
MJ

About

Margaret Johnson is an author at Duke Medical Center specializing in medicine, health services research, and emergency medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

197

2

Health Sciences

1

1

49

3

Nursing

1

1

18

4

Social Sciences

1

1

27

5

Cell Biology

1

1

27

Margaret Johnson

×

16

Publications

430

Citations

12

H-Index

YearCitations

Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial

Fiona M Walter, Helen Morris, Elka Humphrys,

BMJ

2012

67

Brief Report: Chlamydia Psittaci Endocarditis Diagnosed by Blood Culture

Daniel S. Shapiro, Shannon C. Kenney, Margaret Johnson,

New England Journal of Medicine

1992

62

Evaluating diagnostic strategies for early detection of cancer: the CanTest framework

Fiona M Walter, Matthew Thompson, Ian Wellwood,

BMC Cancer

2019

53

U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data reporting

Raul C. Braylan, Susan K. Atwater, Lawrence W. Diamond,

Cytometry

1997

49

Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma

David C. Lin, Joseph Najbauer, Paul M. Salvaterra,

NeuroImage

2007

27

The Cost-Effectiveness of a Novel SIAscopic Diagnostic Aid for the Management of Pigmented Skin Lesions in Primary Care: A Decision-Analytic Model

Ed Wilson, Jon Emery, Ann Louise Kinmonth,

Value in Health

2013

25

Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence

Margaret Johnson, April Bell, Kristen L. Lauing,

Clinical Cancer Research

2023

23

Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma

Katherine B. Peters, Candice Alford, Amy Heltemes,

Neuro-Oncology Practice

2023

19

Utilization of Hospice Services in a Population of Patients With Huntington's Disease

Margaret Johnson, Samuel Frank, Matthew T. Mendlik,

Journal of Pain and Symptom Management

2017

18

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

Hao‐Wen Sim, Elizabeth H Barnes, Sonia Yip,

Neuro-Oncology Advances

2023

17

Page 1